533
Views
1
CrossRef citations to date
0
Altmetric
Research Article

Large Middle Cerebral Artery Infarctions and the Hyperdense Middle Cerebral Artery Sign in Patients with Atrial Fibrillation

, &
Pages 261-268 | Published online: 09 Jul 2009

REFERENCES

  • BAMFORD J., SANDERCOCK R, DENNIS M., BURN J. & WAR-LOW C.: Classification and natural history of clinically identifiable subtypes of cerebral infarction. Lancet 337 (1991), 1521.
  • BASTIANELLO S., PIERALLINI A., COLONNESE C. et al.: Hyp-erdense middle cerebral artery CT sign. Comparison with angiography in the acute phase of ischemic supratentorial infarction. Neuroradiology 33 (1991), 207.
  • BERGE E., ABDELNOOR M., NAKSTAD P H. & SANDSET P. M.: Low molecular-weight heparin versus aspirin in pa-tients with acute ischaemic stroke and atrial fibrillation. A double-blind randomised study. Lancet 355 (2000), 1205.
  • BoGoussiAvsKY J., VAN MELLE G. & REGLI F.: The Lausan-ne Stroke Registry. Analysis of 1,000 consecutive patients with first stroke. Stroke 19 (1988), 1083.
  • BUTTNER T., UFFMANN M., Gus N. & KOSTER O.: Early CCT signs of supratentorial brain infarction. Clinico-radiological correlations. Acta Neurol. Scand. 96 (1997), 317.
  • CEREBRAL EMBOLISM TASK FORCE: Cardiogenic brain em-bolism: The second report of the Cerebral Embolism Task Force (published erratum appears in Arch. Neurol. 46 (1989), 1079). Arch. Neurol. 46 (1989), 727.
  • DONNAN G. A. & LEVI C. R.: Large and panhemispheric infarcts. In: Stroke syndromes. Edited by J. Bogousslav-sky & L. Caplan. Cambridge University Press, New York 1995.
  • HACKE W, KASTE M., FIESCHI C. et al.: Intravenous throm-bolysis with recombinant tissue plasminogen activator for acute hemispheric stroke. The European Cooperative Acute Stroke Study (ECASS). JAMA 274 (1995), 1017.
  • HEINSIUS T., BOGOUSSLAVSKY J. & VAN MELLE G.: Large infarcts in the middle cerebral artery territory. Etiology and outcome patterns (published erratum appears in Neur-ology 50 (1998), 1940). Neurology 50 (1998), 341.
  • INTERNATIONAL STROKE TRIAL COLLABORATIVE GROUP: The International Stroke Trial (1ST): A randomised trial of as-pirin, subcutaneous heparin, both, or neither among 19435 patients with acute ischaemic stroke. Lancet 349 (1997), 1569.
  • JORGENSEN H. S., NAKAYAMA H., REITH J., RAASCHOU H. 0. & OLSEN T. S.: Acute stroke with atrial fibrillation. The Copenhagen Stroke Study. Stroke 27 (1996), 1765.
  • KLEINBAUM D. G., KUPPER L. L. & MORGENSTERN H.: Epi-demiologic research. Principles and quantitative methods. Van Nostrand Reinhold Co New York 1982.
  • LEYS D., PRUVO J. P, GODEFROY 0., RONDEPIERRE P. & LE-CLERC X.: Prevalence and significance of hyperdense middle cerebral artery in acute stroke. Stroke 23 (1992), 317.
  • LIN H. J., WOLF P A., KELLY-HAYES M., BEISER A. S. & KASE C. S.: Stroke severity in atrial fibrillation. Stroke 27 (1996), 1760.
  • LINDLEY R. I., WADDELL E, LIVINGSTONE M. et al.: Can simple questions assess outcome after stroke? Cerebrovasc. Dis. 4 (1994), 314.
  • MAHONEY E I. & BARTHEL D. W: Functional evaluation. The Barthel index. Md. State. Med. J. 14 (1965), 61.
  • MANELFE C., LARRUE V, VON KUMMER R. et al.: Associ-ation of hyperdense middle cerebral artery sign with clin-ical outcome in patients treated with tissue plasminogen activator. Stroke 30 (1999), 769.
  • MOHR J. P, GAUTIER J. C. & HIER D. B.: Middle cerebral artery disease. In: Stroke. Pathophysiology, diagnosis, and management. Vol. 1, 2nd edn. Edited by H. J. M. Barnett et al. Churchill Livingstone, New York 1992.
  • MOULIN T., CATTIN E, CREPIN-LEBLOND T. et al.: Early CT signs in acute middle cerebral artery infarction. Predictive value for subsequent infarct locations and outcome. Neur-ology 47 (1996), 366.
  • RINGELSTEIN E. B., KOSCHORKE S., HOLLING A., THRON A., LAMBERTZ H. & MINALE C.: Computed tomogmphic pat-terns of proven embolic brain infarctions. Ann. Neurol. 26 (1989), 759.
  • SANDERCOCK P, BAMFORD J., DENNIS M. et al.: Atrial fib-rillation and stroke. Prevalence in different types of stroke and influence on early and long-term prognosis (Oxfordshi-re Community Stroke Project). BMJ 305 (1992), 1460.
  • SCANDINAVIAN STROKE STUDY GROUP: Multicenter trial of hemodilution in ischemic stroke: Background and study protocol. Stroke 16 (1985), 885.
  • TIMSIT S. G., SACCO R. L., MOHR J. P et al.: Brain infarc-tion severity differs according to cardiac or arterial embolic source. Neurology 43 (1993), 728). 267
  • TomsicK T. A.: Sensitivity and prognostic value of early CT in occlusion of the middle cerebral artery trunk. AJNR 15 (1994), 16.
  • TOMSICK T., BROTT T., BARSAN W. et al.: Prognostic value of the hyperdense middle cerebral artery sign and stroke scale score before ultraearly thrombolytic therapy. AJNR 17 (1996), 79.
  • TURPIE A. G. & CONNOLLY S. J.: Antithrombotic therapy in atrial fibrillation. Can. Fam. Physician 42 (1996), 1341.
  • URBACH H., BRECHTELSBAUER D., KLOTZ S., BENDSZUS M. & SOLYMOSI L.: Erkennbarkeit frischer Media-Infarkte im CT. Zeitliches Auftreten von Ischamiezeichen. ROFO 166 (1997), 502.
  • VAN SWIETEN J. C., KOUDSTAAL P. J., VISSER M. C., SCHOUTEN H. J. & VAN GUN J.: Interobserver agreement for the assessment of handicap in stroke patients. Stroke 19 (1988), 604.
  • VON KUMMER R., MEYDING-LAMADE U., FORSTING M. et al.: Sensitivity and prognostic value of early CT in occlusion of the middle cerebral artery trunk. AJNR 15 (1994), 9.
  • YAMANOUCHI H., TOMONAGA M., SHIMADA H., MATSUSHITA S., KURAMOTO K. & TOYOKURA Y.: Nonvalvular atrial fib-rillation as a cause of fatal massive cerebral infarction in the elderly. Stroke 20 (1989), 1653.
  • YocK D. H. JR: CT demonstration of cerebral emboli. J. Comput. Assist. Tomogr. 5 (1981), 190.
  • ZORZON M., MASE G., Pozzi-MucELLI F et al.: Increased density in the middle cerebral artery by nonenhanced com-puted tomography. Prognostic value in acute cerebral in-farction. Eur. Neurol. 33 (1993), 256.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.